Poly Medicure Ltd
NSE:POLYMED

Watchlist Manager
Poly Medicure Ltd Logo
Poly Medicure Ltd
NSE:POLYMED
Watchlist
Price: 2 582.15 INR -0.27% Market Closed
Market Cap: 261.5B INR
Have any thoughts about
Poly Medicure Ltd?
Write Note

Intrinsic Value

The intrinsic value of one POLYMED stock under the Base Case scenario is 1 217.29 INR. Compared to the current market price of 2 582.15 INR, Poly Medicure Ltd is Overvalued by 53%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

POLYMED Intrinsic Value
1 217.29 INR
Overvaluation 53%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Poly Medicure Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for POLYMED cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about POLYMED?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Poly Medicure Ltd

Provide an overview of the primary business activities
of Poly Medicure Ltd.

What unique competitive advantages
does Poly Medicure Ltd hold over its rivals?

What risks and challenges
does Poly Medicure Ltd face in the near future?

Has there been any significant insider trading activity
in Poly Medicure Ltd recently?

Summarize the latest earnings call
of Poly Medicure Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Poly Medicure Ltd.

Provide P/S
for Poly Medicure Ltd.

Provide P/E
for Poly Medicure Ltd.

Provide P/OCF
for Poly Medicure Ltd.

Provide P/FCFE
for Poly Medicure Ltd.

Provide P/B
for Poly Medicure Ltd.

Provide EV/S
for Poly Medicure Ltd.

Provide EV/GP
for Poly Medicure Ltd.

Provide EV/EBITDA
for Poly Medicure Ltd.

Provide EV/EBIT
for Poly Medicure Ltd.

Provide EV/OCF
for Poly Medicure Ltd.

Provide EV/FCFF
for Poly Medicure Ltd.

Provide EV/IC
for Poly Medicure Ltd.

Show me price targets
for Poly Medicure Ltd made by professional analysts.

What are the Revenue projections
for Poly Medicure Ltd?

How accurate were the past Revenue estimates
for Poly Medicure Ltd?

What are the Net Income projections
for Poly Medicure Ltd?

How accurate were the past Net Income estimates
for Poly Medicure Ltd?

What are the EPS projections
for Poly Medicure Ltd?

How accurate were the past EPS estimates
for Poly Medicure Ltd?

What are the EBIT projections
for Poly Medicure Ltd?

How accurate were the past EBIT estimates
for Poly Medicure Ltd?

Compare the revenue forecasts
for Poly Medicure Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Poly Medicure Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Poly Medicure Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Poly Medicure Ltd compared to its peers.

Compare the P/E ratios
of Poly Medicure Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Poly Medicure Ltd with its peers.

Analyze the financial leverage
of Poly Medicure Ltd compared to its main competitors.

Show all profitability ratios
for Poly Medicure Ltd.

Provide ROE
for Poly Medicure Ltd.

Provide ROA
for Poly Medicure Ltd.

Provide ROIC
for Poly Medicure Ltd.

Provide ROCE
for Poly Medicure Ltd.

Provide Gross Margin
for Poly Medicure Ltd.

Provide Operating Margin
for Poly Medicure Ltd.

Provide Net Margin
for Poly Medicure Ltd.

Provide FCF Margin
for Poly Medicure Ltd.

Show all solvency ratios
for Poly Medicure Ltd.

Provide D/E Ratio
for Poly Medicure Ltd.

Provide D/A Ratio
for Poly Medicure Ltd.

Provide Interest Coverage Ratio
for Poly Medicure Ltd.

Provide Altman Z-Score Ratio
for Poly Medicure Ltd.

Provide Quick Ratio
for Poly Medicure Ltd.

Provide Current Ratio
for Poly Medicure Ltd.

Provide Cash Ratio
for Poly Medicure Ltd.

What is the historical Revenue growth
over the last 5 years for Poly Medicure Ltd?

What is the historical Net Income growth
over the last 5 years for Poly Medicure Ltd?

What is the current Free Cash Flow
of Poly Medicure Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Poly Medicure Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Poly Medicure Ltd

Current Assets 19.2B
Cash & Short-Term Investments 12.6B
Receivables 3.3B
Other Current Assets 3.3B
Non-Current Assets 11.3B
Long-Term Investments 442.9m
PP&E 9.8B
Intangibles 551.4m
Other Non-Current Assets 495.8m
Current Liabilities 4.2B
Accounts Payable 1.5B
Other Current Liabilities 2.7B
Non-Current Liabilities 440.1m
Long-Term Debt 23.5m
Other Non-Current Liabilities 416.5m
Efficiency

Earnings Waterfall
Poly Medicure Ltd

Revenue
15.2B INR
Cost of Revenue
-5.1B INR
Gross Profit
10.1B INR
Operating Expenses
-6.8B INR
Operating Income
3.3B INR
Other Expenses
-382.6m INR
Net Income
2.9B INR

Free Cash Flow Analysis
Poly Medicure Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In Q2 FY '25, Poly Medicure reported impressive revenue growth of 23%, on track to meet its 22-24% annual guidance. The operating EBITDA margin improved to 28%, up from 25.82% the previous year, demonstrating a margin target increase of 100-150 basis points for the full year. Significant growth was noted in the renal business, expected to reach INR 150 crores for FY '25. Export business thrived, logging a 35% growth, particularly in Europe. They aim for $2-$3 million in the U.S. this year, with a long-term target of $15-$20 million. The company continues investing in new plants to double its renal capacity, fortifying its growth trajectory.

What is Earnings Call?
Fundamental Scores

POLYMED Profitability Score
Profitability Due Diligence

Poly Medicure Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Exceptional Revenue Growth Forecast
Positive 3-Year Average ROE
60/100
Profitability
Score

Poly Medicure Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

POLYMED Solvency Score
Solvency Due Diligence

Poly Medicure Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

Poly Medicure Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

POLYMED Price Targets Summary
Poly Medicure Ltd

Wall Street analysts forecast POLYMED stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for POLYMED is 2 394.71 INR with a low forecast of 2 050.3 INR and a high forecast of 2 992.5 INR.

Lowest
Price Target
2 050.3 INR
21% Downside
Average
Price Target
2 394.71 INR
7% Downside
Highest
Price Target
2 992.5 INR
16% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for POLYMED?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for POLYMED is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

POLYMED Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Poly Medicure Ltd Logo
Poly Medicure Ltd

Country

India

Industry

Health Care

Market Cap

261.5B INR

Dividend Yield

0.12%

Description

Poly Medicure Ltd. engages in the provision and sales of medical devices. The company is headquartered in Faridabad, Haryana. The company went IPO on 2011-12-05. The firm is primarily in the business of manufacture and sale of medical devices. The firm offers a diverse portfolio of medical devices in the product verticals of infusion therapy, oncology, anesthesia and respiratory care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices, and others. The company supplies its products to approximately 110 countries, in Europe, Africa, Americas, Australia, and Asia. Its products include suction control valve, safety arterial cannula, VTM Kit, VLTM kit, blood collection needle with flashback, and pre-filled syringes. The firm operate eight manufacturing facilities across India, China, Egypt, and Italy. In India, it operates five manufacturing facilities, three of which are situated at Faridabad (Haryana), and one each in Jaipur (Rajasthan) and Haridwar (Uttarakhand).

Contact

HARYANA
Faridabad
Plot No.104-105 & 115-116 , Sector-59, HSIDC Industrial Area, Ballabgarh,
+911292307000
www.polymedicure.com

IPO

2011-12-05

Employees

2 039

Officers

CEO, MD & Director
Mr. Himanshu Baid
Founder & Non Executive Director
Mr. Jugal Kishore Baid
Chief Financial Officer
Mr. Naresh Vijayvergiya
Company Secretary & Compliance Officer
Mr. Avinash Chandra
Joint MD & Executive Director
Mr. Rishi Baid B.S.M.E
President of Corporate Sales & Marketing
Mr. Vishal Baid C.A.
Show More
Assistant Vice President of Finance & Accounts
Mr. P. K. Rastogi C.A.
Senior Vice President of Domestic Sales & Marketing
Mr. Hemant Bhalla B.Sc.
President of R&D
Mr. Pankaj Kumar Gupta B.E.
President of Sales & Marketing - India
Mr. Manish Sardana
Show Less

See Also

Discover More
What is the Intrinsic Value of one POLYMED stock?

The intrinsic value of one POLYMED stock under the Base Case scenario is 1 217.29 INR.

Is POLYMED stock undervalued or overvalued?

Compared to the current market price of 2 582.15 INR, Poly Medicure Ltd is Overvalued by 53%.

Back to Top